{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T23:28:40Z","timestamp":1769210920862,"version":"3.49.0"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,17]],"date-time":"2023-04-17T00:00:00Z","timestamp":1681689600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008730","name":"The Norwegian Cancer Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008730","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology Open Science"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.euros.2023.04.005","type":"journal-article","created":{"date-parts":[[2023,5,15]],"date-time":"2023-05-15T10:08:42Z","timestamp":1684145322000},"page":"6-15","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["The Longitudinal Course of Prospectively Recorded Patient-reported Outcomes in Prostate Cancer Patients Treated with Surgery and Salvage Radiotherapy"],"prefix":"10.1016","volume":"53","author":[{"given":"Line V.","family":"Hjelle","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie","family":"S\u00e6len","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erling","family":"Aars\u00e6ther","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tore","family":"Knutsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sigve","family":"Andersen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne G.","family":"Bentzen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elin","family":"Richardsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tom","family":"Wilsgaard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sophie D.","family":"Foss\u00e5","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hege S.","family":"Haugnes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.euros.2023.04.005_b0005","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.eururo.2016.08.003","article-title":"EAU-ESTRO-SIOG guidelines on prostate cancer. Part 1: screening, diagnosis, and local treatment with curative intent","volume":"71","author":"Mottet","year":"2017","journal-title":"Eur Urol"},{"key":"10.1016\/j.euros.2023.04.005_b0010","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.urology.2011.08.045","article-title":"Long-term biochemical recurrence rates after robot-assisted radical prostatectomy: analysis of a single-center series of patients with a minimum follow-up of 5 years","volume":"79","author":"Suardi","year":"2012","journal-title":"Urology"},{"key":"10.1016\/j.euros.2023.04.005_b0015","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.euros.2020.06.005","article-title":"Risk of recurrent disease 6 years after open or robotic-assisted radical prostatectomy in the prospective controlled trial LAPPRO","volume":"20","author":"Nyberg","year":"2020","journal-title":"Eur Urol Open Sci"},{"key":"10.1016\/j.euros.2023.04.005_b0020","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1016\/S0140-6736(21)01790-6","article-title":"The addition of androgen deprivation therapy and pelvic lymph node treatment to prostate bed salvage radiotherapy (NRG Oncology\/RTOG 0534 SPPORT): an international, multicentre, randomised phase 3 trial","volume":"399","author":"Pollack","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.euros.2023.04.005_b0025","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1080\/21681805.2020.1782980","article-title":"A comparison of side-effects and quality-of-life in patients operated on for prostate cancer with and without salvage radiation therapy","volume":"54","author":"Braide","year":"2020","journal-title":"Scand J Urol"},{"key":"10.1016\/j.euros.2023.04.005_b0030","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/j.urology.2010.01.027","article-title":"Development and validation of an abbreviated version of the expanded prostate cancer index composite instrument for measuring health-related quality of life among prostate cancer survivors","volume":"76","author":"Szymanski","year":"2010","journal-title":"Urology"},{"key":"10.1016\/j.euros.2023.04.005_b0035","doi-asserted-by":"crossref","first-page":"e473","DOI":"10.1016\/j.prro.2015.02.015","article-title":"Phase 2 trial of guideline-based postoperative image guided intensity modulated radiation therapy for prostate cancer: toxicity, biochemical, and patient-reported health-related quality-of-life outcomes","volume":"5","author":"Berlin","year":"2015","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.euros.2023.04.005_b0040","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/j.eururo.2019.05.011","article-title":"Patient-reported outcomes and late toxicity after postprostatectomy intensity-modulated radiation therapy","volume":"76","author":"Akthar","year":"2019","journal-title":"Eur Urol"},{"key":"10.1016\/j.euros.2023.04.005_b0045","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1754-9485.2012.02464.x","article-title":"Health-related quality of life using intensity-modulated radiation therapy for post-prostatectomy radiotherapy","volume":"57","author":"van Gysen","year":"2013","journal-title":"J Med Imaging Radiat Oncol"},{"key":"10.1016\/j.euros.2023.04.005_b0050","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1080\/21681805.2020.1854343","article-title":"Prostatectomy with or without post-operative radiotherapy: long-term adverse effects and quality of life","volume":"55","author":"Vatne Monsen","year":"2021","journal-title":"Scand J Urol"},{"key":"10.1016\/j.euros.2023.04.005_b0055","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1111\/apm.12533","article-title":"International Society of Urological Pathology (ISUP) grading of prostate cancer\u2014an ISUP consensus on contemporary grading","volume":"124","author":"Egevad","year":"2016","journal-title":"Apmis"},{"key":"10.1016\/j.euros.2023.04.005_b0060","unstructured":"EAU guidelines. https:\/\/uroweb.org\/guideline\/prostate-cancer\/."},{"key":"10.1016\/j.euros.2023.04.005_b0065","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.ijrobp.2009.02.006","article-title":"Development of RTOG consensus guidelines for the definition of the clinical target volume for postoperative conformal radiation therapy for prostate cancer","volume":"76","author":"Michalski","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.euros.2023.04.005_b0070","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/j.ijrobp.2015.03.021","article-title":"Consensus guidelines and contouring atlas for pelvic node delineation in prostate and pelvic node intensity modulated radiation therapy","volume":"92","author":"Harris","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.euros.2023.04.005_b0075","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.radonc.2008.05.006","article-title":"Post-prostatectomy radiation therapy: Consensus guidelines of the Australian and New Zealand Radiation Oncology Genito-Urinary Group","volume":"88","author":"Sidhom","year":"2008","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.euros.2023.04.005_b0080","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/S1470-2045(16)00111-X","article-title":"Salvage radiotherapy with or without short-term hormone therapy for rising prostate-specific antigen concentration after radical prostatectomy (GETUG-AFU 16): a randomised, multicentre, open-label phase 3 trial","volume":"17","author":"Carrie","year":"2016","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.euros.2023.04.005_b0085","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1056\/NEJMoa1607529","article-title":"Radiation with or without antiandrogen therapy in recurrent prostate cancer","volume":"376","author":"Shipley","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.euros.2023.04.005_b0090","unstructured":"Michigan Medicine, University of Michigan. Scoring instructions for the Expanded Prostate cancer Index Composite Short Form (EPIC-26). https:\/\/medicine.umich.edu\/sites\/default\/files\/content\/downloads\/Scoring%20 Instructions%20for%20the%20EPIC%2026.pdf."},{"key":"10.1016\/j.euros.2023.04.005_b0095","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/S1053-4296(03)00024-9","volume":"13","author":"Aziz","year":"2003","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/j.euros.2023.04.005_b0100","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.urology.2014.08.044","article-title":"Minimally important difference for the Expanded Prostate Cancer Index Composite Short Form","volume":"85","author":"Skolarus","year":"2015","journal-title":"Urology"},{"key":"10.1016\/j.euros.2023.04.005_b0105","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1001\/jama.2019.20675","article-title":"Patient-reported outcomes through 5 years for active surveillance, surgery, brachytherapy, or external beam radiation with or without androgen deprivation therapy for localized prostate cancer","volume":"323","author":"Hoffman","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.euros.2023.04.005_b0110","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.prro.2012.05.005","article-title":"Intensity modulated radiation therapy after radical prostatectomy: Early results show no decline in urinary continence, gastrointestinal, or sexual quality of life","volume":"3","author":"Corbin","year":"2013","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.euros.2023.04.005_b0115","doi-asserted-by":"crossref","first-page":"38.e17","DOI":"10.1016\/j.urolonc.2019.09.012","article-title":"Impact of timing on salvage radiation therapy adverse events following radical prostatectomy: a secondary analysis of the RTOG 9601 cohort","volume":"38","author":"Baumgarten","year":"2020","journal-title":"Urol Oncol"},{"key":"10.1016\/j.euros.2023.04.005_b0120","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/S1470-2045(18)30357-7","article-title":"Robot-assisted laparoscopic prostatectomy versus open radical retropubic prostatectomy: 24-month outcomes from a randomised controlled study","volume":"19","author":"Coughlin","year":"2018","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.euros.2023.04.005_b0125","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1111\/j.1464-410X.2010.09579.x","article-title":"Five year Expanded Prostate cancer Index Composite-based quality of life outcomes after prostatectomy for localized prostate cancer","volume":"107","author":"Parker","year":"2011","journal-title":"BJU Int"},{"key":"10.1016\/j.euros.2023.04.005_b0130","doi-asserted-by":"crossref","first-page":"18","DOI":"10.4111\/icu.2018.59.1.18","article-title":"Factors associated with testosterone recovery after androgen deprivation therapy in patients with prostate cancer","volume":"59","author":"Nam","year":"2018","journal-title":"Investig Clin Urol"},{"key":"10.1016\/j.euros.2023.04.005_b0135","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.eururo.2021.05.033","article-title":"Dose-intensified versus conventional-dose salvage radiotherapy for biochemically recurrent prostate cancer after prostatectomy: the SAKK 09\/10 randomized phase 3 trial","volume":"80","author":"Ghadjar","year":"2021","journal-title":"Eur Urol"},{"key":"10.1016\/j.euros.2023.04.005_b0140","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1001\/jama.281.17.1591","article-title":"Natural history of progression after PSA elevation following radical prostatectomy","volume":"281","author":"Pound","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.euros.2023.04.005_b0145","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1080\/0284186X.2017.1314006","article-title":"Pre- and post-prostatectomy variables associated with pelvic post-operative radiotherapy in prostate cancer patients: a national registry-based study","volume":"56","author":"Vatne","year":"2017","journal-title":"Acta Oncol"},{"key":"10.1016\/j.euros.2023.04.005_b0150","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.eururo.2019.03.016","article-title":"External validation of the European Association of Urology biochemical recurrence risk groups to predict metastasis and mortality after radical prostatectomy in a European cohort","volume":"75","author":"Tilki","year":"2019","journal-title":"Eur Urol"}],"container-title":["European Urology Open Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666168323001921?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666168323001921?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T20:09:17Z","timestamp":1762978157000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666168323001921"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":30,"alternative-id":["S2666168323001921"],"URL":"https:\/\/doi.org\/10.1016\/j.euros.2023.04.005","relation":{},"ISSN":["2666-1683"],"issn-type":[{"value":"2666-1683","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Longitudinal Course of Prospectively Recorded Patient-reported Outcomes in Prostate Cancer Patients Treated with Surgery and Salvage Radiotherapy","name":"articletitle","label":"Article Title"},{"value":"European Urology Open Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euros.2023.04.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier B.V. on behalf of European Association of Urology.","name":"copyright","label":"Copyright"}]}}